Format

Send to

Choose Destination
J Control Release. 2015 Feb 28;200:87-96. doi: 10.1016/j.jconrel.2014.12.041. Epub 2014 Dec 30.

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics.

Author information

1
Department of Neurosurgery, University Medical Center Utrecht, The Netherlands; Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands.
2
Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
3
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
4
Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, The Netherlands.
5
Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University, The Netherlands. Electronic address: e.n.m.nolte@uu.nl.

Abstract

Nano-sized extracelullar vesicles (EVs) released by various cell types play important roles in a plethora of (patho)physiological processes and are increasingly recognized as biomarkers for disease. In addition, engineered EV and EV-inspired liposomes hold great potential as drug delivery systems. Major technologies developed for high-throughput analysis of individual EV include nanoparticle tracking analysis (NTA), tunable resistive pulse sensing (tRPS) and high-resolution flow cytometry (hFC). Currently, there is a need for comparative studies on the available technologies to improve standardization of vesicle analysis in diagnostic or therapeutic settings. We investigated the possibilities, limitations and comparability of NTA, tRPS and hFC for analysis of tumor cell-derived EVs and synthetic mimics (i.e. differently sized liposomes). NTA and tRPS instrument settings were identified that significantly affected the quantification of these particles. Furthermore, we detailed the differences in absolute quantification of EVs and liposomes using the three technologies. This study increases our understanding of possibilities and pitfalls of NTA, tRPS and hFC, which will benefit standardized and large-scale clinical application of (engineered) EVs and EV-mimics in the future.

KEYWORDS:

Exosomes; Extracellular vesicles; High-resolution flow cytometry; Liposomes; Nanoparticle tracking analysis; Tunable resistive pulse sensing

PMID:
25555362
PMCID:
PMC4324667
DOI:
10.1016/j.jconrel.2014.12.041
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center